Verapamil Hydrochloride Extended-Release Tablets — Class II drug recall D-0436-2023
Terminated recall by Amerisource Health Services LLC, reported 2023-03-15, distributed nationwide. Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was abo
| Recall number | D-0436-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2023-01-27 |
| Classified | 2023-03-06 |
| Reported by FDA | 2023-03-15 |
| Terminated | 2024-05-12 |
| Distributed | Nationwide (US) |
| Quantity | 422 cartons |
| Reason classes | specification failure |
| NDC | 60687-0493-01, 60687-0493-11 |
| Lot numbers | 1009065 |
| Expiration dates | 2023-12-31 |
Product
Verapamil Hydrochloride Extended-Release Tablets, USP, 120 mg, Rx Only, 100 Tablets per Carton (10 x 10), Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-493-01; NDC Unit Dose: 60687-493-11.
Reason for recall
Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0436-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.